Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment

被引:18
作者
Roozenburg, BJ
vanDessel, JHM
Evers, JLH
Bots, RSGM
机构
[1] ST ELIZABETH HOSP, DEPT OBSTET & GYNAECOL, DIV FERTIL, NL-5022 GC TILBURG, NETHERLANDS
[2] ACAD HOSP MAASTRICHT, DEPT OBSTET & GYNAECOL, NL-6202 AZ MAASTRICHT, NETHERLANDS
关键词
endogenous opioids; naltrexone; normogonadotrophic ovarian failure; ovulation induction; polycystic ovary;
D O I
10.1093/humrep/12.8.1720
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Patients suffering from normogonadotrophic anovulation and infertility are initially treated with clomiphene citrate, Those who do not respond to clomiphene citrate usually receive gonadotrophin treatment which is labour-intensive, expensive, and associated with an increased risk of multiple pregnancies and ovarian hyperstimulation syndrome, We treated 22 patients with clomiphene resistant normogonadotrophic anovulation with naltrexone (an opioid receptor blocker) alone or naltrexone in combination with an anti-oestrogen, In 19 patients ovulation and resumption of a regular menstrual cycle was achieved and in 12 out of 19 a singleton pregnancy was observed, In conclusion, ovulation can be induced successfully using naltrexone alone or naltrexone in combination with an anti-oestrogen in clomiphene citrate resistant anovulatory patients, Compared to gonadotrophin induction of ovulation, this method is safe, simple and inexpensive.
引用
收藏
页码:1720 / 1722
页数:3
相关论文
共 16 条
[1]  
[Anonymous], 1995, HUM REPROD, V10, P1549
[2]  
[Anonymous], 1996, HUM REPROD, V11, P1779
[3]   OVULATION INDUCTION WITH A SINGLE-BLIND TREATMENT REGIMEN COMPARING NALTREXONE, PLACEBO AND CLOMIPHENE CITRATE IN WOMEN WITH SECONDARY AMENORRHEA [J].
ARMEANU, MC ;
MOSS, RJ ;
SCHOEMAKER, J .
ACTA ENDOCRINOLOGICA, 1992, 126 (05) :410-415
[4]  
BUVAT J, 1989, FERTIL STERIL, V52, P553
[5]  
CAGNACCI A, 1994, FERTIL STERIL, V62, P269
[6]   EVEN AFTER PRIMING WITH OVARIAN-STEROIDS OR PULSATILE GONADOTROPIN-RELEASING-HORMONE ADMINISTRATION, NALTREXONE IS UNABLE TO INDUCE OVULATION IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA [J].
COUZINET, B ;
YOUNG, J ;
BRAILLY, S ;
CHANSON, P ;
SCHAISON, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2102-2107
[7]   THE STEP-DOWN PRINCIPLE IN GONADOTROPIN TREATMENT AND THE ROLE OF GNRH ANALOGS [J].
FAUSER, BCJM ;
DONDERWINKEL, P ;
SCHOOT, DC .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1993, 7 (02) :309-330
[8]  
FRANKS S, 1985, CLIN OBSTET GYNAECOL, V12, P605
[9]   NALTREXONE TREATMENT RESTORES MENSTRUAL CYCLES IN PATIENTS WITH WEIGHT LOSS-RELATED AMENORRHEA [J].
GENAZZANI, AD ;
VOLPOGNI, C ;
PETRAGLIA, F ;
GAMBA, O ;
GASTALDI, M ;
GENAZZANI, AR .
FERTILITY AND STERILITY, 1995, 64 (05) :951-956
[10]   LOW-DOSE GONADOTROPIN THERAPY FOR INDUCTION OF OVULATION IN 100 WOMEN WITH POLYCYSTIC-OVARY-SYNDROME [J].
HAMILTONFAIRLEY, D ;
KIDDY, D ;
WATSON, H ;
SAGLE, M ;
FRANKS, S .
HUMAN REPRODUCTION, 1991, 6 (08) :1095-1099